Aduro Biotech

develops clinical-stage biotechnology immunotherapy solutions for the treatment of cancer...
Read more
Aduro Biotech Chairman & CEO: Stephen T. Isaacs

Chairman & CEO

Stephen T. Isaacs

CEO Approval Rating

87/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
100-250
Agree?
Funding
$239.6M
Acquisitions
3

Aduro Biotech Competitors

1Immune Design
2Agenus
3Activelifescientific
4Atreca
5Citryll
6GT Biopharma
7Inovio
8Kite Pharma
9NexImmune

Trending Companies